Trading Signals: BAX Stock Price Prediction and Forecast (Mon. Dec. 1, 2014 - Wed. Sep. 27, 2023)(Baxter International Inc.)
| BAX latest price $44.4400 (0.23%) ($44.0600 - $44.7400) on Tue. Jan. 3, 2017. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.35% (three month average) | RSI | 33 | Latest Price | $44.4400(0.23%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BAX advances 0.1% a day on average for past five trading days. | Weekly Trend | BAX declines -0.7% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support BAX advance at 0% a week (0% probability) XLV(58%) SPLV(52%) VYM(51%) IVE(49%) IWD(49%) | Factors Impacting BAX price | BAX will decline at least -0.675% in a week (0% probabilities). TLT(-18%) VIXM(-16%) GDXJ(-8%) UUP(-5%) TIP(-4%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.675% (StdDev 1.35%) | Hourly BBV | 0 () | Intraday Trend | 0.1% | | | |
|
5 Day Moving Average | $44.32(0.27%) | 10 Day Moving Average | $44.28(0.36%) | 20 Day Moving Average | $44.43(0.02%) | To recent high | -9.6% | To recent low | 1.9% | Market Cap | $22.673b | | | | Baxter International, Inc. provides portfolio of essential renal and hospital products, including acute and chronic dialysis, sterile IV solutions, infusion systems and devices, parenteral nutrition therapies; premixed and oncolytic injectable, bio surgery products and anesthetics, drug reconstitution systems; and pharmacy automation, software and services. It operates through the following segment: Americas, Europe, Middle East & Africa and Asia-Pacific. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL. |